doi: 10.1002/art.21625.
The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
- PMID: 16453282
- DOI: 10.1002/art.21625
Item in Clipboard
The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials
Arthritis Rheum.
2006 Feb.
Free article
No abstract available
Similar articles
-
Development of classification and response criteria for rheumatic diseases.Arthritis Rheum. 2006 Jun 15;55(3):348-52. doi: 10.1002/art.22003. Arthritis Rheum. 2006. PMID: 16739201
-
The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.Arthritis Rheum. 2006 Jun 15;55(3):355-63. doi: 10.1002/art.22002. Arthritis Rheum. 2006. PMID: 16739203
-
Treatment of lupus nephritis.Semin Nephrol. 1996 Nov;16(6):527-35. Semin Nephrol. 1996. PMID: 9125797 Review.
-
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.Arthritis Rheum. 2004 Nov;50(11):3418-26. doi: 10.1002/art.20628. Arthritis Rheum. 2004. PMID: 15529383
-
Rituximab treatment in lupus nephritis--where do we stand?Lupus. 2013 Apr;22(4):381-9. doi: 10.1177/0961203312471574. Lupus. 2013. PMID: 23553781 Review.
Cited by
-
Comparison of three spot proteinuria measurements for pediatric nephrotic syndrome: based on the International pediatric Nephrology Association 2022 Guidelines.Ren Fail. 2023;45(2):2253324. doi: 10.1080/0886022X.2023.2253324. Epub 2023 Sep 19. Ren Fail. 2023. PMID: 37724557 Free PMC article.
-
Predictive Factors for Renal Response in Lupus Nephritis: A Single-center Prospective Cohort Study.J Rheum Dis. 2022 Oct 1;29(4):223-231. doi: 10.4078/jrd.22.0006. Epub 2022 Jul 5. J Rheum Dis. 2022. PMID: 37476428 Free PMC article.
-
Significance of co-positivity for anti-dsDNA, -nucleosome, and -histone antibodies in patients with lupus nephritis.Ann Med. 2023 Dec;55(1):1009-1017. doi: 10.1080/07853890.2023.2187076. Ann Med. 2023. PMID: 36896834 Free PMC article.
-
C4d as a Screening Tool and an Independent Predictor of Clinical Outcomes in Lupus Nephritis and IgA Nephropathy.Front Med (Lausanne). 2022 Jan 31;9:832998. doi: 10.3389/fmed.2022.832998. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35174193 Free PMC article.
-
Outcome selection for tissue-agnostic drug trials for immune-mediated inflammatory diseases: a systematic review of core outcome sets and regulatory guidance.Trials. 2022 Jan 15;23(1):42. doi: 10.1186/s13063-022-06000-w. Trials. 2022. PMID: 35033186 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
